France Onychomycosis Market Size & Outlook, 2023-2030
France onychomycosis market, 2018-2030 (US$M)
Related Markets
France onychomycosis market highlights
- The France onychomycosis market generated a revenue of USD 142.7 million in 2023 and is expected to reach USD 197.4 million by 2030.
- The France market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating treatment in 2023.
- Topical is the most lucrative treatment segment registering the fastest growth during the forecast period.
Onychomycosis market data book summary
| Market revenue in 2023 | USD 142.7 million |
| Market revenue in 2030 | USD 197.4 million |
| Growth rate | 4.7% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Topical |
| Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
Other key industry trends
- In terms of revenue, France accounted for 4.1% of the global onychomycosis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany onychomycosis market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 175.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Onychomycosis Market Scope
Onychomycosis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France onychomycosis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.67% in 2023. Horizon Databook has segmented the France onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
France's onychomycosis market is expected to grow at a lucrative rate over the forecast period. Moreover, the rapidly aging population & increasing diabetes prevalence in the country are expected to support market expansion. According to a study published by PubMed Central in November 2021, over 25% of the French population was aged 60 or more in January 2020.
In addition, the article projects that France may have around 4 million elderly citizens in 2050, representing 16.4% of individuals aged 60 or over. Moreover, the rising prevalence of diabetes is anticipated to increase the incidence of onychomycosis in France.
According to a study published by BioMed Central Ltd., in February 2023, about 3.5 million individuals, or 5.3% of the population in France, were treated for diabetes in 2020. In addition, older individuals and diabetic patients are more prone to onychomycosis.
Reasons to subscribe to France onychomycosis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France onychomycosis market databook
-
Our clientele includes a mix of onychomycosis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into France onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France onychomycosis market size, by treatment, 2018-2030 (US$M)
France Onychomycosis Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
